While I'm in the car--not driving--on my way to the airport to go to the FDA Advisory Committee meeting on drug-coated stents I wanted to pass along some news from the Eli Lilly analyst meeting this morning in New York that I just left.
So, it took the torpedoeing of torcetrapib to get new Pfizer CEO Jeff Kindler to finally talk to us. He came on "Power Lunch" today for his first TV interview since taking the helm more than four months ago. A former litigator, he is media savvy, telegenic and a smooth-talker. I don't know why he didn't come on before he was put in the position of serious crisis management with a major hole to fill in the company's drug pipeline and about a ten percent decline in the stock price.
Saturday night Pfizer dropped a bombshell. Two days after the company announced it planned--if all went well--to file for FDA approval of its developmental cholesterol pill Torcetrapib in the second half of next year, Pfizer suddenly pulled the plug on the drug. Tests had shown this pill raises good cholesterol and lowers bad. But the FDA says early Saturday morning Pfizer's Independent Data Safety Monitoring Board told the company about people who died in a clinical trial.
Earlier this year a crew working for documentary filmmaker Michael Moore "crashed" the major scientific oncology conference in Atlanta. Moore's reportedly working on a movie with the working title of "Sicko" about the country's healthcare system and the pharmaceutical industry.
President Barack Obama addresses the state of the economy, including the steady decline in unemployment, and increase in U.S. oil production. "2014 needs to be a year of action," he says.
Friday, 20 Dec 2013 | 11:41 AM ET
John Chen, Blackberry CEO discusses the Foxconn deal and how he will convince his current enterprise customers not to leave the BlackBerry server. Chen also weighs in on the NSA and the security of the network.
Friday, 20 Dec 2013 | 7:00 AM ET
The rules: Both ladies must purchase the same 3 gifts online from their respective retailers, using any method to receive those items—home delivery, locker pickup, in-store pickup. It's the competitor's choice!